Login to Your Account

Rinat Secures $40M In Series B Round To Advance Neuro Drugs

By Aaron Lorenzo

Thursday, August 21, 2003
Rinat Neuroscience Corp. returned to the private financing well and brought in $40 million through a Series B round that will fund drug development for the next several years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription